Literature DB >> 31070550

Ethical Issues to Consider Before Introducing Neurotechnological Thought Apprehension in Psychiatry.

Gerben Meynen1.   

Abstract

When it becomes available, neuroscience-based apprehension of subjective thoughts is bound to have a profound impact on several areas of society. One of these areas is medicine. In principle, medical specialties that are primarily concerned with mind and brain are most likely to apply neurotechnological thought apprehension (NTA) techniques. Psychiatry is such a specialty, and the relevance of NTA developments for psychiatry has been recognized. In this article, I discuss ethical issues regarding the use of NTA techniques in psychiatric contexts. First, I consider the notion of neurotechnological "thought apprehension," as well as some limitations of present-day NTA applications. Next, I identify ethical priorities for its possible future use in psychiatry. The topics I explore concern key (bio)ethical issues: confidentiality, trust and distrust, consent and coercion, and, finally, responsibility. I conclude that mental health-related use of NTA entails some specific ethical concerns that deserve careful attention before introducing these technologies in psychiatric practice.

Entities:  

Keywords:  Neuroethics; mind reading; neurolaw; neurotechnology; psychiatry

Mesh:

Year:  2019        PMID: 31070550     DOI: 10.1080/21507740.2019.1595772

Source DB:  PubMed          Journal:  AJOB Neurosci        ISSN: 2150-7759


  3 in total

1.  Ethical Analysis of "Mind Reading" or "Neurotechnological Thought Apprehension": Keeping Potential Limitations in Mind.

Authors:  Peter Zuk; Gabriel Lázaro-Muñoz
Journal:  AJOB Neurosci       Date:  2019-05-09

2.  Neurotechnologies Cannot Seize Thoughts: A Call for Caution in Nomenclature.

Authors:  Katherine E MacDuffie; Sara Goering
Journal:  AJOB Neurosci       Date:  2019 Jan-Mar

3.  Forensic Brain-Reading and Mental Privacy in European Human Rights Law: Foundations and Challenges.

Authors:  Sjors Ligthart; Thomas Douglas; Christoph Bublitz; Tijs Kooijmans; Gerben Meynen
Journal:  Neuroethics       Date:  2020-06-20       Impact factor: 1.480

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.